Visual Universitätsmedizin Mainz

Dr. Frank Misselwitz

Head Global Clinical Development Cardiovascular
Bayer Pharma AG, Wuppertal, Germany

Scientific profile

  • Thrombosis
  • Clinical development of rivaroxaban
  • Planning & execution of the phase II & III clinical studies
  • Late life cycle studies
  • Development & approval of Adempas (Riociguat) to treat Pulmonary Arterial Hypertension & Chronic Thrombo-Embolic Pulmonary Hypertension